Trademarkia Logo

Australia

AU$
XAVERZA
Cancelled: Cancelled at the request of IB

Last updated on 2 Nov 2017

Owner Info

Portola Pharmaceuticals, Inc.

270 East Grand Avenue

South San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

1697404 filed on 8 Apr 2015

Correspondent

Harold Milstein Sheppard Mullin Richter & Hampton LLP

379 Lytton Avenue,

Palo Alto CA 94301,

UNITED STATES OF AMERICA

XAVERZA

Classification Information


Class [005]
Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, he Read More

Mark Details


Serial Number

1697404

Registered On

8 Apr 2015

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

4 Feb 2015

Mark Type

US

Legal History


Show more

Status DateAction Taken
2th Nov 2017Cancellation of Entry in Register Published
25th Oct 2017Cancel IP Right
3rd Aug 2017General Correspondence (Application or Registration)
3rd Sept 2015IP Right Registration Published
2th Sept 2015Register Trade Mark
2th Sept 2015Application Status
25th Jun 2015IP Right Acceptance Published
24th Jun 2015User Created Notice correspondence sent
24th Jun 2015Clear Examination report approved
24th Jun 2015Application Accepted correspondence sent